Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions

Asthma with nasal polyps: The “severe” phenotype? ClinicalTrials.gov ID: NCT01513837

José Antonio Castillo, Vicente Plaza, Gustavo Rodrigo, Berta Juliá, César Picado, Joaquim Mullol
European Respiratory Journal 2014 44: P4118; DOI:
José Antonio Castillo
1Servicio de Neumología, Hospital Universitari Quiron Dexeus, Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vicente Plaza
2Servicio de Neumología, Hospital Sta. Creu i Sant Pau, Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gustavo Rodrigo
3Servicio de Neumologia, Hospital de las Fuerzas Armadas, Montevideo, Uruguay
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Berta Juliá
4Departamento Médico, MSD-España, Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
César Picado
5Servicio de Neumología, Hospital Clínic, Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joaquim Mullol
6Immunoal.lèrgia Respiratòria Clínica i Experimental, IDIBAPS & Unitat de Rinologia i Clínica de l’Olfacte, Servei d’ORL, Hospital Clínic, Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

Severe asthma is associated to chronic rhinosinusitis with nasal polyps (CRSwNP).

OBJECTIVE: We sought to investigate whether asthma with nasal polyps and aspirin sensitivity was associated with a specific severe asthma phenotype.

METHODS. A prospective study in 2010-2011 by pneumonologists and ENT specialists in 23 centers, 492 asthmatics age 45(15) yo, 70.5% female, according to GINA: 17.3% intermittent and 82.7% persistent (24.6% mild, 31.4% moderate, and 26.7% severe). Asthma control by ACT.The allergic (AR) and non-allergic (NAR) rhinitis and chronic rhinosinusitis with (CRSwNP) and without (CRSsNP) nasal polyps according to ARIA and EPOS, by symptoms, prick test, nasal endoscopy and sinus CT scan. Aspirin sensitivity (AIA)by clinical history.

RESULTS. 35% of severe asthma patients, predominantly in non-atopic (44%) reported CRSwNP (OR:3.4; p < 0.001). AIA was associated with severe asthma (43%; OR:7.8; p < 0.05) and with the presence of CRSwNP (38.9%; OR:9.05; p < 0.001). Patients with severe asthma and CRSwNP had high symptom score and exacerbation rate, and reported loss of smell (83%, p < 0.001), were mainly non-atopic (p < 0.001), older (p < 0.001), had late onset asthma, and showed higher FeNO levels (p < 0.001). Sinus CT scores (p < 0.001) correlated with poor asthma control. Multiple logistic regression analysis showed that CRSwNP, AIA and late onset asthma were independently associated with severe asthma.

CONCLUSION: Severe asthma with CRSwNP may represent the most “severe phenotype” of asthma being associated with non-atopic, late onset asthma and AIA. These clinical findings suggests that asthma with nasal polyps may be due to a distinct underlying mechanism or “endotype”.

  • Asthma - diagnosis
  • Rhinitis
  • Allergy
  • © 2014 ERS
Previous
Back to top
Vol 44 Issue Suppl 58 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Asthma with nasal polyps: The “severe” phenotype? ClinicalTrials.gov ID: NCT01513837
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Asthma with nasal polyps: The “severe” phenotype? ClinicalTrials.gov ID: NCT01513837
José Antonio Castillo, Vicente Plaza, Gustavo Rodrigo, Berta Juliá, César Picado, Joaquim Mullol
European Respiratory Journal Sep 2014, 44 (Suppl 58) P4118;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Asthma with nasal polyps: The “severe” phenotype? ClinicalTrials.gov ID: NCT01513837
José Antonio Castillo, Vicente Plaza, Gustavo Rodrigo, Berta Juliá, César Picado, Joaquim Mullol
European Respiratory Journal Sep 2014, 44 (Suppl 58) P4118;
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo

Jump To

  • Article
  • Info & Metrics
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Risk of cardiovascular comorbidities in patients with idiopathic pulmonary fibrosis: Analysis of Medicare data
  • Traffic related air pollution and transplant failure
  • Different impact of respiratory symptoms on health care consumption and daily life in Finland, Estonia and Sweden
Show more 6.1 Epidemiology

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2022 by the European Respiratory Society